What is ATEC?
ATEC, headquartered in Carlsbad, California, is a medical technology company dedicated to the design, development, and advancement of technologies for the surgical treatment of spinal disorders. The company's product portfolio encompasses a range of innovative solutions, including the EOS imaging system for full-body imaging, the VEA alignment mobile application, the SafeOp Neural InformatiX System for automated neuromonitoring, and the Valence intra-operative system integrating navigation and robotics. ATEC also offers a comprehensive suite of spinal implants, fixation systems, and biologics designed to enhance surgical outcomes and patient recovery. The company distributes its products through a network of independent sales agents and direct sales representatives, serving both the United States and international markets.
How much funding has ATEC raised?
ATEC has raised a total of $365.7M across 6 funding rounds:
Stock Offering
$83.7M
Debt
$30M
Debt
$50M
Debt
$2M
Debt
$50M
Debt
$150M
Stock Issuance/Offering (2006): $83.7M, investors not publicly disclosed
Debt (2008): $30M led by Silicon Valley Bank and Oxford Finance
Debt (2014): $50M supported by Deerfield Capital Management
Debt (2020): $2M featuring PPP
Debt (2022): $50M backed by MidCap Financial
Debt (2023): $150M with participation from Braidwell
Key Investors in ATEC
Deerfield Capital Management
Deerfield Capital Management is an alternative credit specialist that provides investment solutions across various credit strategies, focusing on delivering risk-adjusted returns. Their expertise in credit cycles and interest rate environments suggests a strategic approach to financing companies with strong growth potential.
Braidwell
Braidwell offers flexible capital and partnership to companies across all stages of development and capital structures, indicating a strategic interest in supporting ATEC's growth trajectory and innovation in human health transformation.
Silicon Valley Bank
Silicon Valley Bank (SVB) is a financial institution that provides commercial and private banking services, particularly to technology and life sciences companies. Their involvement suggests confidence in ATEC's technological advancements and market position within the healthcare sector.
What's next for ATEC?
The recent major strategic investment in ATEC signals a pivotal phase for the company, likely aimed at accelerating product development, expanding market reach, and enhancing its technological capabilities in the competitive medical device industry. With a history of securing significant debt financing, this latest capital infusion suggests a strategic move towards scaling operations and potentially pursuing new market opportunities or acquisitions. The company's focus on advanced surgical technologies for spinal disorders positions it to capitalize on the growing demand for minimally invasive and robotic-assisted procedures, further solidifying its enterprise-level presence.
See full ATEC company page
